Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Morning! Today, we hear Vinay Prasad defend his contentious vaccine position at a closed-door investor conference, see a renowned Harvard computational biologist struggle financially after Trump funding cuts gutted his funding, and more.

Prasad blames media as FDA turmoil deepens

At a closed-door investor conference in New York, FDA vaccines chief Vinay Prasad railed against “misleading media narratives” as backlash mounts over his push to require larger, longer studies for updated vaccines, STAT’s Damian Garde reports. His proposal has drawn an extraordinary public rebuke from 12 former FDA commissioners.

To read the rest of this story subscribe to STAT+. Sub

See Full Page